Impact of hepatitis B core antibody positive donors in lung and heart-lung transplantation: an analysis of the United Network For Organ Sharing Database

Transplantation
Gundeep S DhillonDavid Weill

Abstract

The availability of suitable lung and heart-lung allografts for transplantation remains poor. Accepting organs from donors with positive serological studies for hepatitis B could potentially expand the donor pool. The aim of this study was to assess the impact of donor hepatitis B core antibody (HBcAb) status on outcomes of lung and heart-lung transplant recipients. Using United Network for Organ Sharing/Organ Procurement and Transplantation Network data, we compared outcomes of 13,233 recipients of HBcAb negative organs with 333 recipients of HBcAb positive donor organs. We found that the unadjusted 1-year survival of recipients of HBcAb positive donor was worse, but there was no difference in survival after adjusting for baseline donor and recipient differences. On multivariate analysis, recipient and donor age, procedure type, era of transplant, baseline medical condition, diagnosis, and donor hepatitis C antibody status impacted 1- and 5-year survival. However, donor HBcAb status did not impact 1- or 5-year survival posttransplant. Lung and heart-lung allografts from HBcAb positive donors may be safely used, which would increase the number of transplants performed without compromising recipient outcomes.

References

Jun 1, 1990·Transfusion·J H Hoofnagle
Sep 1, 1997·Gastroenterology·L Mayer
Aug 15, 2003·The New England Journal of Medicine·Ellen SheehyLawrence Hunsicker
Jan 18, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Sean P PinneyDonna Mancini
Apr 26, 2005·Transplantation Proceedings·T M De FeoUNKNOWN Collaborative Kidney, Liver and Heart North Italy Transplant Program Study Groups
Jul 16, 2005·American Journal of Respiratory and Critical Care Medicine·David S WilkesHerbert Y Reynolds
Aug 19, 2007·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Elbert P TrulockMarshall I Hertz
Dec 21, 2007·The New England Journal of Medicine·Jay A Fishman
Feb 12, 2008·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·E A PomfretJ P Roberts

❮ Previous
Next ❯

Citations

Aug 27, 2014·Transplant Infectious Disease : an Official Journal of the Transplantation Society·J L HoranB D Alexander
Jun 20, 2012·Archivos de bronconeumología·Carlos Chamorro, Manuel Aparicio
Apr 23, 2011·Clinics in Chest Medicine·Gregory I Snell, Glen P Westall
Jan 8, 2011·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Daniel F Dilling, Allan R Glanville
Sep 14, 2012·Transplant Infectious Disease : an Official Journal of the Transplantation Society·N MahboobiS M Alavian
Mar 8, 2013·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·J LevitskyUNKNOWN AST Infectious Diseases Community of Practice
Jul 2, 2014·Transplant Infectious Disease : an Official Journal of the Transplantation Society·P ManickamM S Cappell
Feb 25, 2015·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S HuprikarD Kumar
May 16, 2015·Critical Care Medicine·Robert M KotloffUNKNOWN Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Donor
Feb 22, 2011·Transplantation Proceedings·M SalvadoriE Bertoni
Mar 22, 2020·Pediatric Transplantation·Jennifer ConwayAnne I Dipchand
Oct 8, 2020·Current Opinion in Organ Transplantation·Kali Zhou, Selena Zhou
Feb 9, 2021·Transplantation Proceedings·Agnieszka KuczajMichał Zembala

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.